Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
120mg/0.5ml glatiramer acetate[2] Acetate,
Glatiramer		---[1] 13
240 mg glatiramer acetate[2] Acetate,
Glatiramer		---[2] 2, 13
340 mg Glatiramer acetato[1] Glatiramer---[1] 13
4Cyclophosphamide/Glatiramer acetate[3] Acetate,
Cyclophosphamide,
Glatiramer		[2] D00287 ,
D07760 		--[1] 13
5Experimental Glatiramer Acetate[2] Acetate,
Glatiramer		---[1] 13
6Glatiramer[1] Glatiramer---[4] 2, 13, 96, 156
7GLATIRAMER ACETATE[2] Acetate,
Glatiramer		---[3] 13, 96, 156
8Glatiramer Acetate (Copaxone®)[2] Acetate,
Glatiramer		---[2] 13, 156
9Glatiramer Acetate (DB)[2] Acetate,
Glatiramer		---[1] 13
10Glatiramer Acetate (GA)[2] Acetate,
Glatiramer		---[1] 13
11Glatiramer Acetate (GA) 40 mg[2] Acetate,
Glatiramer		---[1] 13
12Glatiramer Acetate (GTR)[2] Acetate,
Glatiramer		---[1] 13
13Glatiramer Acetate (OL)[2] Acetate,
Glatiramer		---[1] 13
14Glatiramer acetate 150mg enteric coated tablets[2] Acetate,
Glatiramer		---[1] 13
15Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets[2] Acetate,
Glatiramer		---[1] 13
16Glatiramer acetate 20 mg[2] Acetate,
Glatiramer		---[1] 13
17Glatiramer acetate 20 mg, with mitoxantrone[3] Acetate,
Glatiramer,
Mitoxantrone		[1] D08224 [2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[1] 13
18Glatiramer Acetate 20 mg/0.5 mL[2] Acetate,
Glatiramer		---[1] 13
19Glatiramer acetate 40 mg[2] Acetate,
Glatiramer		---[1] 13
20Glatiramer Acetate [GA][2] Acetate,
Glatiramer		---[1] 13
21Glatiramer acetate injection with oral cetirizine hydrochloride[3] Acetate,
Cetirizine,
Glatiramer		[1] D07662 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 13
22Glatiramer acetate with minocycline[3] Acetate,
Glatiramer,
Minocycline		[1] D05045 --[1] 13
23Glatiramer acetate, (Copaxone®)[2] Acetate,
Glatiramer		---[1] 13
24Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b[2] Acetate,
Glatiramer		---[1] 13
25Glatiramer Acetate, N-Acetylcysteine[3] Acetate,
Acetylcysteine,
Glatiramer		[1] D00221 --[1] 13
26GLATIRAMER ACETATO[1] Glatiramer---[1] 13
27GLATIRAMERO ACETATO----[1] 13
28Human interferon beta-1a and glatiramer acetate[4] Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		[1] D04554 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
29Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab[12] Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		[10] D01370 ,
D02802 ,
D02994 ,
D03846 ,
D05218 ,
D06886 ,
D09314 ,
D10001 ,
D10172 ,
D11215 		[7] CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		[31] , Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬[1] 13